Michael Maeng

A new important paper on how to treat non-culprit lesions in patients with STEMI is now available in NEJM!

NCL plaques and prognosis by clinical presentation @DavidErlinge @GreggWStone @FrobertOle @ziadalinyc @GroThrane @MichaelMaeng1 ahajournals.org/doi/full/10.11…

Per-patient prevalence of high-risk vulnerable plaques was comparable in STEMI vs NSTEMI, as was the overall long-term incidence of non-culprit lesion-related & all MACE. @MichaelMaeng1 @GroThrane @DavidErlinge @GreggWStone @FrobertOle @ziadalinyc ahajournals.org/doi/10.1161/CI…

@JACCJournals @CGyldenkerne An important paper when trying to understand the risk associated with T2DM. What comes first, the egg or the hen?

@CGyldenkerne @MichaelMaeng1 2-fold more #CVD events starting 3 (!) decades before #T2DM diagnosis compared with the general population. We need early prophylactic intervention! bit.ly/3ZrpgUM (2/2) #JACC #Diabetes @CGyldenkerne @MichaelMaeng1

#JACC POLL: How long before a #diabetes diagnosis do you think your patients have elevated #CVD risk? 🤔 (1/2) #T2D @CGyldenkerne @MichaelMaeng1

@TRUMP_ARMY_ No

BREAKING: Elon Musk is creating an unbiased search engine and email service that will rival Google. WILL YOU USE THIS OVER GOOGLE? A. Yes B. No

@lucasaganronald Stupid question. Don't waste my time.

Would you rate Remco Evenepoel above Jonas Vingegaard as a cyclist or not? Yes, Vingegaard has 2 Tours de France and many stage race titles, but not everything is about Tour and Remco Evenepoel has World and Olympic titles plus also monuments. So who would you rank higher?

@lucasaganronald He is not underrated, just up against Vingo and Pogi🥶

Remco Evenepoel’s palmares at the age of 24: Olympic ITT Champion World ITT & RR Champion European ITT Champion National ITT & RR Champion Vuelta GC 2xLiege-Bastogne-Liege 3xClasica San Sebastian … Remco Evenepoel is the most underrated rider in the world. Change my mind.

@faustocoppi60 But Mads P was there🙂

I didn't see neither Pogacar, Carapaz or Girmay on this boat...hmmm. #Paris2024

@faustocoppi60 Last year Pogi lost big time due to suboptimal prep, this year its Jonas' turn. Next year?

So far, nothing seems to have changed after the last rest day. Pogacar is stronger than Vingegaard and he showed it also today. I'm not that excited anymore for Cime de la Bonette I must say... #TDF2024

@Frank_Huijbers VAR has destroyed my joy in watching football. We need to change the way it is used OR abandon VAR

This is an absolute disgrace with England's penalty in mind! The outcome after this? A freekick against Aké. I rest my case! #netherlandsvsengland #EURO2024 #uefa #NEDENG

@ncurzen Like Denmark in 1992, England will chock the world and win on Sunday, so you better find a replacement and be able to have Carlsberg🙂

Does anyone want to do my on call for primaries on Sunday night ?

Consistent Renal Benefits of Semaglutide in CKD and T2DM Patients With or Without SGLT2 Inhibitors Use. FLOW Trial Written by @ceciliabahit Summary, analysis, and more #ADA2024 coverage below! cardiologynownews.org/consistent-ren… @CMichaelGibson

Thank you @PedersenTorp and Kristian for helping this newbie with the code and to @DLBHATTMD @mvaduganathan @TorBiering @ChristinaBFA @Pallisgaard_MD @MaBMortensen @MichaelMaeng1 @EmilFosb @gunngis @bonde_nissen @ThueOlsen and Lars, Christina, and Anna for perfecting the paper.

Procedural Outcomes After Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease #AHAJournals @jeroen_sonck @MichaelMaeng1 @DMunhoz @belmontemarta1 ahajrnls.org/3UHueY6

Excited to share our findings on 10-year mortality after STEMI, now in @JACCJournals 👉STEMI patients surviving the first 90 days have only mildly elevated mortality compared to a matched general population. doi.org/10.1016/j.jacc… @MichaelMaeng1 #STEMI #cardiotwitter

The manuscript was also picked up by Dr. John Mandrola in his weekly podcast two days ago (podcasts.apple.com/dk/podcast/thi…), and he was very positive with regards to both results and methodology. @drjohnm

A great paper is out in JACC (pubmed.ncbi.nlm.nih.gov/38897670/), where we shows that 90-day survivors following a STEMI has almost the same 10-year mortality as a matched general population. An important message to our patients!😍

An important paper in our understanding of why autoimmune diseases increase the risk of ischemic heart disease! Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events pubmed.ncbi.nlm.nih.gov/38897674/

@faustocoppi60 I think the last 2 stages sums it up pretty well🙂

44th place. Jonas Vingegaard is washed. #OGC24

@soudalquickstep Cheech and Chong

Name a more iconic duo. We’ll wait.